13F HOLDINGS REPORT
Flagship Pioneering Inc.
Quarter ended Q1 2024 · Filed May 15, 2024 · Accession 0000950123-24-005589
Total Value
$1.52B
Positions
13
Other Managers
3
Confidential Omitted
No
Holdings (13)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Moderna Inc | MRNA | 9,662,114 | $1.03B | 67.53% |
| 2 | Sana Biotechnology Inc | SANA | 15,909,178 | $159.1M | 10.44% |
| 3 | Sana Biotechnology Inc | SANA | 9,092,678 | $90.9M | 5.96% |
| 4 | Omega Therapeutics Inc | 68217N105 | 22,240,723 | $81.2M | 5.32% |
| 5 | Foghorn Therapeutics Inc | FHTX | 9,330,878 | $62.6M | 4.11% |
| 6 | Denali Therapeutics Inc | DNLI | 1,364,516 | $28.0M | 1.84% |
| 7 | Omega Therapeutics Inc | 68217N105 | 6,984,856 | $25.5M | 1.67% |
| 8 | Foghorn Therapeutics Inc | FHTX | 3,343,242 | $22.4M | 1.47% |
| 9 | Seres Therapeutics Inc | MCRB | 14,664,169 | $11.4M | 0.74% |
| 10 | Seres Therapeutics Inc | MCRB | 8,452,876 | $6.5M | 0.43% |
| 11 | Syros Pharmaceuticals Inc | 87184Q206 | 1,000,000 | $5.3M | 0.35% |
| 12 | Syros Pharmaceuticals Inc | 87184Q206 | 293,849 | $1.6M | 0.10% |
| 13 | Moderna Inc | MRNA | 3,924 | $418,141 | 0.03% |